Pascal Stock Today

PAS Stock  CAD 0.015  0.00  0.00%   
Market Performance
0 of 100
Odds Of Distress
Over 96
Pascal Biosciences is selling for under 0.015 as of the 7th of February 2023; that is No Change since the beginning of the trading day. The stock's lowest day price was 0.015. Pascal Biosciences has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Pascal Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of January 2023 and ending today, the 7th of February 2023. Click here to learn more.
Fiscal Year End
Pascal Biosciences Inc., a drug discovery and development company, researches and develops biotechnology products for the treatment of cancer and for the enhancement of immune system in Canada. Pascal Biosciences Inc. is headquartered in Vancouver, Canada. The company has 65.59 M outstanding shares of which 7.72 K shares are at this time shorted by private and institutional investors with about 44.62 days to cover all short positions. More on Pascal Biosciences
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Pascal Biosciences Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pascal Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pascal Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President CEOPatrick Gray
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Pascal Biosciences' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellFairly Valued
Pascal Biosciences (PAS) is traded on TSX Venture Exchange in Canada and employs 2 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 983.92 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pascal Biosciences's market, we take the total number of its shares issued and multiply it by Pascal Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pascal Biosciences classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 65.59 M outstanding shares of which 7.72 K shares are at this time shorted by private and institutional investors with about 44.62 days to cover all short positions. Pascal Biosciences has accumulated about 1.58 M in cash with (614.93 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Pascal Biosciences Probability Of Bankruptcy
Pascal Biosciences owns a total of sixty-five million five hundred ninety-four thousand eight hundred outstanding shares. Pascal Biosciences holds 5.08 pct. if its outstanding shares held by insiders and 5.08 pct. owned by third-party entities . Please note that no matter how much assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Ownership Allocation

Check Pascal Ownership Details

Pascal Stock Price Odds Analysis

Depending on a normal probability distribution, the odds of Pascal Biosciences jumping above the current price in 90 days from now is about 73.36%. The Pascal Biosciences probability density function shows the probability of Pascal Biosciences stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Pascal Biosciences has a beta of -0.1455 indicating as returns on benchmark increase, returns on holding Pascal Biosciences are expected to decrease at a much lower rate. During the bear market, however, Pascal Biosciences is likely to outperform the market. Additionally, the company has an alpha of 0.2578, implying that it can generate a 0.26 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 0.015HorizonTargetOdds Above 0.015
26.54%90 days
Based on a normal probability distribution, the odds of Pascal Biosciences to move above the current price in 90 days from now is about 73.36 (This Pascal Biosciences probability density function shows the probability of Pascal Stock to fall within a particular range of prices over 90 days) .

Pascal Biosciences Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Pascal Biosciences market risk premium is the additional return an investor will receive from holding Pascal Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pascal Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Pascal Biosciences' alpha and beta are two of the key measurements used to evaluate Pascal Biosciences' performance over the market, the standard measures of volatility play an important role as well.

Pascal Stock Against Markets

Picking the right benchmark for Pascal Biosciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Pascal Biosciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Pascal Biosciences is critical whether you are bullish or bearish towards Pascal Biosciences at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Pascal Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Analyst Recommendations Now


Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

Pascal Biosciences Corporate Directors

Pascal Biosciences corporate directors refer to members of a Pascal Biosciences board of directors. The board of directors generally takes responsibility for the Pascal Biosciences' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Pascal Biosciences' board members must vote for the resolution. The Pascal Biosciences board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

Invested in Pascal Biosciences?

The danger of trading Pascal Biosciences is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Pascal Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Pascal Biosciences. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Pascal Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please check Your Equity Center. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for analysis

When running Pascal Biosciences price analysis, check to measure Pascal Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pascal Biosciences is operating at the current time. Most of Pascal Biosciences' value examination focuses on studying past and present price action to predict the probability of Pascal Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pascal Biosciences' price. Additionally, you may evaluate how the addition of Pascal Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Please note, there is a significant difference between Pascal Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Pascal Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pascal Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.